Cargando…
LPTO-01. LEPTOMENINGEAL METASTASIS FROM OVARIAN CARCINOMA TREATED WITH SYSTEMIC HIGH-DOSE METHOTREXATE
BACKGROUND: Central nervous system metastasis in ovarian cancer is reported in approximately 1% of cases and typically localizes to the parenchyma. Leptomeningeal disease (LMD) is exceedingly rare. Prognosis is extremely poor with median survival of 60 days. Given the rarity of LMD in ovarian cancer...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213275/ http://dx.doi.org/10.1093/noajnl/vdz014.024 |